Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 58, Issue 4, Pages 1225-1235
Publisher
Wiley
Online
2013-03-21
DOI
10.1002/hep.26404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HRas Signal Transduction Promotes Hepatitis C Virus Cell Entry by Triggering Assembly of the Host Tetraspanin Receptor Complex
- (2013) Laetitia Zona et al. Cell Host & Microbe
- Interferon signaling in the liver during hepatitis C virus infection
- (2012) Zuzanna Makowska et al. CYTOKINE
- Persistence of HCV in Quiescent Hepatic Cells Under Conditions of an Interferon-Induced Antiviral Response
- (2012) Oliver Bauhofer et al. GASTROENTEROLOGY
- New Virologic Tools for Management of Chronic Hepatitis B and C
- (2012) Stéphane Chevaliez et al. GASTROENTEROLOGY
- Anti−Hepatitis C Virus Drugs in Development
- (2012) Esperance A.K. Schaefer et al. GASTROENTEROLOGY
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons
- (2012) Emmanuel Thomas et al. GASTROENTEROLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Liver regeneration
- (2012) Nelson Fausto et al. JOURNAL OF HEPATOLOGY
- Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges
- (2012) Mirjam B. Zeisel et al. JOURNAL OF HEPATOLOGY
- Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals
- (2012) Haihong Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis C Virus NS5A Disrupts STAT1 Phosphorylation and Suppresses Type I Interferon Signaling
- (2012) Kattareeya Kumthip et al. JOURNAL OF VIROLOGY
- Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry
- (2012) J. Diao et al. JOURNAL OF VIROLOGY
- Ephrin receptor: a door to KSHV infection
- (2012) Chris Boshoff NATURE MEDICINE
- Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
- (2012) S. Chakraborty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - A potentially lethal cocktail
- (2011) Michael Charlton HEPATOLOGY
- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
- (2011) Jean-Michel Pawlotsky HEPATOLOGY
- STAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response
- (2011) W.-B. Wang et al. JOURNAL OF IMMUNOLOGY
- New targets for antiviral therapy of chronic hepatitis C
- (2011) Sandra Bühler et al. LIVER INTERNATIONAL
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
- (2011) Joachim Lupberger et al. NATURE MEDICINE
- Host receptor tyrosine kinases mediate HCV entry and are a promising new target for antiviral therapy
- (2011) Natalie J. Wood Nature Reviews Gastroenterology & Hepatology
- Boceprevir for Chronic HCV Genotype 1 Infection
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
- (2011) Vince D. Cataldo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of liver regeneration by growth factors and cytokines
- (2010) Friederike Böhm et al. EMBO Molecular Medicine
- Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
- (2010) Michael T. Dill et al. GASTROENTEROLOGY
- Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
- (2010) Mirjam B. Zeisel et al. JOURNAL OF HEPATOLOGY
- Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
- (2010) S. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
- (2010) Alexander Karlas et al. NATURE
- Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6
- (2010) Melodie L Weller et al. NATURE MEDICINE
- Virus–host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies
- (2010) Philippe Georgel et al. TRENDS IN MOLECULAR MEDICINE
- Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
- (2009) Xuejun Xu et al. PLoS One
- Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection
- (2008) Liliana Soroceanu et al. NATURE
- Interferon signaling and treatment outcome in chronic hepatitis C
- (2008) M. Sarasin-Filipowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network
- (2008) Sandra Morandell et al. PROTEOMICS
- Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
- (2008) Gabriella Regis et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now